Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.

Also called NCT06007222

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
OCEAN-SHD Study Group (from the registry)
Registry
  • NCT NCT06007222
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06007222. Randomized; no masking; primary purpose treatment. Start 2023-04-06 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial
Condition
Aortic Stenosis
Condition
TAVI(Transcatheter Aortic Valve Implantation)
Condition
Aspirin
Condition
DAPT(Dual Antiplatelet Therapy)
Condition
SAPT(Single Antiplatelet Therapy)
Intervention (Drug)
Aspirin group
Intervention (Drug)
Non-antithrombotic group
Lead sponsor
OCEAN-SHD Study Group (class: other)

Record details

Record id
cardio:ct-nct06007222
Content hash
9c3dff843bbcbed9df2cc0962bcef13be0d7a1b8e4ffbc0a90acad5bba09b47f